Mylan Acquisition Of India's Agila Could Get Government Approval Soon
PharmAsia News
August 13, 2013
Executive Summary
The delayed Mylan Laboratories acquisition of Agila Specialties may soon get the blessing of India's Foreign Investment Promotion Board, although the investment would still face other government agencies.
The delayed Mylan Laboratories acquisition of Agila Specialties may soon get the blessing of India's Foreign Investment Promotion Board, although the investment would still face other government agencies. Mylan's nearly $1 billion purchase of Agila, the injectables division of Strides Arcolab, was put on hold while the government considered limits on the amount a foreign company would be allowed to invest in a local company.